Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Post Holdings Announces $500M Share Repurchase Authorization

Post Holdings, Inc. has announced a new $500 million share repurchase authorization, effective from November 27, 2025. This comes after the cancellation of their previous $500 million share repurchase authorization, which was in effect from August 29, 2025, and was terminated on November 26, 2025.

As of November 25, 2025, Post Holdings, Inc. had repurchased approximately $275.2 million under its previous authorization. The new authorization allows for repurchases to be made from time to time in the open market, in private purchases, through forward, derivative, accelerated repurchase or automatic purchase transactions, or otherwise. Any shares repurchased would be held as treasury stock.

Post Holdings, Inc., headquartered in St. Louis, Missouri, is a consumer packaged goods holding company with businesses operating in the center-of-the-store, refrigerated, foodservice, and food ingredient categories. Its businesses include Post Consumer Brands, Weetabix, Michael Foods, and Bob Evans Farms. Post Consumer Brands is a leader in the North American branded and private label ready-to-eat cereal and granola, pet food, nut butter, and pasta categories. Weetabix is home to the United Kingdom’s number one selling ready-to-eat cereal brand, Weetabix®. Michael Foods and Bob Evans Farms are leaders in refrigerated foods, delivering innovative, value-added egg and refrigerated potato side dish products to the foodservice and retail channels. As a result of these announcements, the company's shares have moved 1.78% on the market, and are now trading at a price of $102.82. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS